1997Archives of DermatologyRequires access

The Truth About Erythema Migrans

Henry M. Feder

Open publisher page 9 citations

Abstract

LYME DISEASE in Europe and the United States is caused by different strains of the spirocheteBorrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.1-3For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termederythema chronicum migrans(ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States. In this issue of theArchives, Hulshof and colleagues4from the Netherlands report on the excellent outcome of 44 European patients

About this research paper

What this paper is about

LYME DISEASE in Europe and the United States is caused by different strains of the spirocheteBorrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.1-3For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termederythema chronicum migrans(ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States. In this issue of theArchives, Hulshof and colleagues4from the Netherlands report on the excellent outcome of 44 European patients

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

LYME DISEASE in Europe and the United States is caused by different strains of the spirocheteBorrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.1-3For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termederythema chronicum migrans(ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States. In this issue of theArchives, Hulshof and colleagues4from the Netherlands report on the excellent outcome of 44 European patients

Key concepts: Erythema chronicum migrans, Borrelia burgdorferi, Erythema migrans, Dermatology, Medicine, Lyme disease, Rash, Pathognomonic

Related papers

Back to paper searchBrowse research topicsOriginal source
The Truth About Erythema Migrans — Research Paper | ScholarLens